1265P IMpower150: A post hoc analysis of efficacy outcomes in patients with KRAS, STK11 and KEAP1 mutations
Howard West, Federico Cappuzzo, Martin Reck, Tony Mok, Robert M. Jotte, Makoto Nishio, E. Kim, S. Morris, G. Shankar, W. Zou, D. Shames, Mark L. McCleland, Mark A. Socinski
Topics & Concepts
MedicineKRASSTK11Internal medicineAtezolizumabPopulationOncologyCancerNivolumabGastroenterologyImmunotherapyColorectal cancerEnvironmental healthCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsColorectal Cancer Treatments and Studies